Loading...
Mixed Asset Passive

KBSTAR Healthcare Fixed Income Balanced (253290)

Update : 2022.07.07

NAV

11,010KRW

+4.03상승 (0.04%)

Market Price per share (KRW)

11,010KRW

+15상승 (0.14%)

※ t-1 last price

trading volume

4,821shares

AUM

KRW 13.2billion

KBSTAR Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2022.07.07
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB KBSTAR HealthCare FixedIncome Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 13,212,580,612
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 11,010
※ t-1 last price
11,010 4,821
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB KBSTAR HealthCare FixedIncome Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
13,212,580,612 하나은행
Market Price per share (KRW) iNAV per share (KRW)
11,010
※ t-1 last price
11,010
Trading Volume (shares)
4,821
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2022-07-07
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB01875-2412(21-10) 25.68
2 KTB01125-2406(21-4) 18.21
3 KTB02375-2703(22-1) 14.66
4 원화예금 11.07
5 F 202209 10.59
6 KBSTAR HealthCare 9.37
7 Celltrion Healthcare 2.48
8 Celltrion 2.43
9 SAMSUNG BIOLOGICS 2.14
10 HLB 1.44

proportion by sectors

Update : 2022.07.07
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 52.21
2 47.79

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2019-06-07 2019-06-11 50
2019-12-07 2019-12-11 34
2020-06-09 2020-06-11 10
2021-06-09 2021-06-11 10
2021-12-09 2021-12-13 11
2022-06-09 2022-06-13 16

Performance

performance

excel download

Update : 2022-07-07

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV -1.06 -2.28 -5.41 -12.05 7.72 -7.75 10.50
Benchmark Index -0.96 -2.23 -5.07 -11.69 8.54 -7.45 13.22
Outperformance -0.11 -0.05 -0.34 -0.37 -0.82 -0.3 -2.73

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2022.07.06 11,010 0.136상승 11,006.45 1.590상승
2022.07.05 10,995 1.711상승 10,834.09 0.458상승
2022.07.04 10,810 0.278상승 10,784.62 0.004상승
2022.07.01 10,780 0.092상승 10,813.73 0.131상승
2022.06.30 10,770 -0.323하락 10,799.56 -0.210하락
2022.06.29 10,805 -0.230하락 10,822.37 0.064상승
2022.06.28 10,830 0.138상승 10,815.38 0.110상승
2022.06.27 10,815 0.417상승 10,803.47 0.004상승
2022.06.24 10,770 1.508상승 10,607.83 -0.504하락
2022.06.23 10,610 -0.562하락 10,661.57 -0.203하락
2022.06.22 10,670 0.329상승 10,683.31 0.595상승
2022.06.21 10,635 0.424상승 10,620.05 -0.401하락
2022.06.20 10,590 - 10,662.82 0.005상승
2022.06.17 10,590 -0.516하락 10,656.64 -0.258하락
2022.06.16 10,645 -0.374하락 10,684.21 -0.851하락
2022.06.15 10,685 -0.372하락 10,775.93 -0.322하락
2022.06.14 10,725 -0.417하락 10,810.77 -1.717하락
2022.06.13 10,770 -1.778하락 10,999.7 0.004상승
2022.06.10 10,965 -0.363하락 11,071.76 0.137상승
2022.06.09 11,005 -0.407하락 11,056.51 0.317상승
2022.06.08 11,050 0.045상승 11,021.56 -1.099하락

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value
Weight(%) Market price (KRW)
1 KTB01875-2412(21-10) KR103501GBC2 583,333,333 25.68 9,695
2 KTB01125-2406(21-4) KR103501GB67 416,666,667 18.21 9,621
3 KTB02375-2703(22-1) KR103501GC33 333,333,333 14.66 9,682
4 원화예금 KRD010010001 243,766,749 11.07 -
5 F 202209 KR4165S90000 2.23 10.59 104
6 KBSTAR HealthCare KR7253280002 18,141 9.37 11,375
7 Celltrion Healthcare KR7091990002 751 2.48 72,600
8 Celltrion KR7068270008 287 2.43 186,500
9 SAMSUNG BIOLOGICS KR7207940008 59 2.14 800,000
10 HLB KR7028300002 888 1.44 35,750
11 Yuhan KR7000100008 475 1.23 57,100
12 SKBS KR7302440003 198 1.09 121,500
13 HanmiPharm KR7128940004 68 0.98 317,500
14 SKBP KR7326030004 254 0.88 75,900
15 SD Biosensor KR7137310009 335 0.66 43,300
16 SEEGENE KR7096530001 339 0.61 39,400
17 Celltrionph KR7068760008 162 0.6 81,900
18 Hanmi Science KR7008930000 210 0.39 40,550
19 GC Corp KR7006280002 51 0.39 170,000
20 ST Pharm KR7237690003 93 0.39 92,700
21 Hugel KR7145020004 80 0.38 105,700
22 DAEWOONG PHARM KR7069620003 42 0.34 177,500
23 CHA Biotech KR7085660009 371 0.25 14,600
24 HANALL BIOPHARMA KR7009420001 329 0.25 16,900
25 MedyTox KR7086900008 46 0.24 112,500
26 BIONEER KR7064550007 207 0.24 25,450
27 DENTIUM KR7145720009 61 0.24 86,300
28 HK inno.N KR7195940002 135 0.24 38,850
29 HUMASIS KR7205470008 297 0.23 17,300
30 BukwangPharm KR7003000007 577 0.23 8,600
31 GC CELL KR7144510005 74 0.2 58,700
32 ILDONG PHARM KR7249420001 151 0.2 28,750
33 SCD KR7000250001 126 0.18 32,150
34 GCH Corp KR7005250006 202 0.18 19,650
35 Binex KR7053030003 261 0.18 14,900
36 PharmaResearch KR7214450009 56 0.17 65,900
37 Amicogen KR7092040005 151 0.16 23,600
38 Lutronic KR7085370005 193 0.16 18,150
39 Jeisys Medical KR7287410005 463 0.15 7,240
40 IlyangPharm KR7007570005 126 0.13 22,500
41 JWPHARMA KR7001060003 119 0.13 23,600
42 YUNGJIN PHARM KR7003520004 838 0.13 3,500
43 CLASSYS KR7214150005 161 0.11 14,400
44 DIO KR7039840004 86 0.1 25,800
45 VATECH KR7043150002 65 0.09 30,550
46 KUP KR7033270000 84 0.09 22,450
47 Boditech KR7206640005 166 0.09 12,050
48 DongwhaPharm KR7000020008 160 0.08 10,350
49 REYON KR7102460003 67 0.07 22,550
50 UBCARE KR7032620007 224 0.05 5,290
51 KOREA PHARMA KR7032300006 31 0.03 24,350
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.